Tian, Xiao-Peng <br/><br/>
A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  07 2020 
 - 3760-3770 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-19-4207  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Clinical Decision-Making--methods<br/>CpG Islands--genetics<br/>DNA Methylation<br/>Disease-Free Survival<br/>F-Box-WD Repeat-Containing Protein 7--genetics<br/>Female<br/>Follow-Up Studies<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--epidemiology<br/>Nomograms<br/>Patient Selection<br/>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma--genetics<br/>Predictive Value of Tests<br/>Receptor, Notch1--genetics<br/>Retrospective Studies<br/>Risk Assessment--methods